Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
CORALAB Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
High and stable operating margin
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Weak price momentum
Low and declining ROE
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0739118.
Snapshot
See detailed analysis
CORALAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
CORALAB Bulk, Block & Insider Trades
CORALAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which in... Read More
Key personnel
Mrs. Sushma Shashi KadkadeD
Chief Financial Officer, Director
Mrs. Dhwani Karna Desai
Compliance Officer, Company Secretary
Mr. Girish M. DhamejaD
Whole Time Director
Mr. Rajendrasinh RanaD
Additional Non-Executive Director
Mr. Malay DoshiD
Non-Executive Independent Director
Mrs. Sheela R. KamdarD
Non-Executive Independent Director
Dr. Saurabh ShahD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Coral Laboratories Ltd.?
The current share price of Coral Laboratories Ltd. is ₹ 444.25 as of 09 Jan 2026.
What is the PE ratio of Coral Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Coral Laboratories Ltd. is 9.15 as of the latest financial data.
What is the ROE and ROCE of Coral Laboratories Ltd.?
Coral Laboratories Ltd. has a Return on Equity (ROE) of 8.33% and a Return on Capital Employed (ROCE) of 7.53% as per the latest financial reports.
What is the market cap of Coral Laboratories Ltd.?
The market capitalization of Coral Laboratories Ltd. stands at ₹ 158.73 Cr.
What is the dividend yield of Coral Laboratories Ltd.?
The dividend yield of Coral Laboratories Ltd. is 0.34% based on the current market price.
What is the RSI of Coral Laboratories Ltd.?
The Relative Strength Index (RSI) of Coral Laboratories Ltd. is 41.52.
What is the FII and DII holding in Coral Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Coral Laboratories Ltd. shares.
What sector does Coral Laboratories Ltd. belong to?
Coral Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Coral Laboratories Ltd. stock?
The beta of Coral Laboratories Ltd. stock is 0.92, indicating its volatility relative to the broader market.
